Home > Boards > US OTC > Delisted > CardioVascular BioTherapeutics (fka CVBT)

<u>Major Venturis Therapeutics News &ndash; DO NOT OVERLOOK</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
walhall Member Profile
 
Followed By 0
Posts 328
Boards Moderated 1
Alias Born 09/15/16
160x600 placeholder
P&G Elects Jon Moeller as President, CEO
Procter & Gamble Co. on Thursday said Vice Chairman and Chief Operating Officer Jon R. Moeller will become the company's president and chief executive, effective Nov. 1.
Aflac Chosen as Administrator for Connecticut Paid Leave Program
Gilead Sciences Raises Fiscal Year Product Sales Forecast
Top Stories of the Day
Top Company News of the Day
Edwards Lifesciences Swings to 2Q Profit, Points to Recovery Signs
Edwards Lifesciences Raises Annual Sales Guidance
Gilead Sciences Swings to 2Q Profit as Revenue Soars 21%
T-Mobile Boosts Parts of Guidance
T-Mobile's Top, Bottom Lines Climb for 2Q
Front Month Nymex RBOB Gasoline Rose 1.87% to Settle at $2.3514 -- Data Talk
Advanced Micro Devices Trades at Record Levels After Xilinx's Strong Earnings Report
Front Month Nymex Natural Gas Rose 2.32% to Settle at $4.0590 -- Data Talk
Baxter International On Pace for Largest Percent Decrease in Nearly a Year -- Data Talk
STOXX Europe 50 Index Ends 0.34% Higher at 3569.62 -- Data Talk
CAC 40 Index Ends 0.37% Higher at 6633.77 -- Data Talk
DAX Ends 0.45% Higher at 15640.47 -- Data Talk
EURO STOXX 50 Index Ends 0.33% Higher at 4116.77 -- Data Talk
FTSE 100 Index Ends 0.88% Higher at 7078.42 -- Data Talk
STOXX Europe 600 Index Ends 0.46% Higher at 463.84 -- Data Talk
Enel 1st Half Net Profit, Revenue Fell; Confirms 2021 Targets
London Indexes Boosted by Positive Welcome to Most Earnings
L'Oreal Posts Higher Profit, Sales in 1st Half
Yum! Brands Reports FX Gains at KFC, Pizza Hut Units -- Currency Comment
Cognizant Technology On Track for Largest Percent Increase In Nearly a Year -- Data Talk
Eli Lilly, Kumquat Biosciences Form Cancer Collaboration
Lilly, Incyte Get Emergency Use Authorization for Covid-19 Treatment as Monotherapy
U.S. Pending Home Sales Fell in June, Missing Expectations -- NAR
Consumer Spending Seen Up in June -- Data Week Ahead
walhall   Monday, 06/29/20 06:56:18 AM
Re: None
Post # of 3567 
Major Venturis Therapeutics News – DO NOT OVERLOOK

There have been two (2) really significant news developments at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) that have been noted on this board, but I’m going to draw attention to them today (and keep them in front of everyone regularly) because they are so important.

1) A Venturis Therapeutics insider who left the company spoke to someone I know who is also a shareholder, and he/she spilled the beans on what’s really going on at Venturis / CVBT.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891

2) Venturis Therapeutics was AGAIN caught red-handed trying to cover up bad news. This is a pattern with the dishonest leadership team of Calvin Wallen III and Grant Gordon, where Venturis says something publicly and it subsequently blows up on them, and then they try to pretend it was never said in the first place. Unfortunately Venturis’s mindset about covering things up is pre-Internet when search engines didn’t exist. But what would you expect from dishonest uneducated dropouts, who between the two of them have only one high school diploma and no college or advanced degrees? But ooops...you won't find those facts in their bios.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156561987

The bottom line: This zombie company has suffered a catastrophic 7-figure loss in a binding arbitration case that it now pretends did not happen, and that it can not pay. Once the final dollar figure is declared by the judge, an aggressive collection effort is likely to commence. I believe it will result in either the liquidation of Venturis Therapeutics or a bankruptcy filing that results in the same. All roads lead to liquidation and the end of Venturis Therapeutics, and soon.

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156515237


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences